|
|
|
|
|
NIDDK Home : Research Funding : NIDDK SBIR/STTR program |
NIDDK SBIR / STTR Program
Small Business Innovation Research (SBIR)
The NIH SBIR program is intended to support innovative research, conducted by small business concerns, which has the potential for commercialization. The program is designed in a two-step fashion where applicants submit a feasibility, or Phase I, application that is peer-reviewed. Typically these applications seek up to $100,000 for 6 months of research support. Successful recipients of Phase I funds may then submit Phase II applications, for both a longer duration (usually 2 years) and a larger amount (usually up to $750,000)of support. The funds for this program are 'set-aside' and therefore do not compete with the regular research, training, or other special programs supported by the Institutes.
In fiscal year (FY) 2002 (October 1, 2002-September 30, 2002), the NIH issued SBIR and STTR grant and contract awards totaling over $490 million.
NIDDK awarded over $32 million in SBIR grants and $1.7 million in STTR grants in FY 2002.
[Top]
Small Business Technology Transfer (STTR)
The NIH STTR program
is similar to the SBIR, but requires that the small business concern
partner with a research institution to perform the project that
will lead to a commercial product.
The major differences between the Small Business Innovation Research
(SBIR) and the Small Business Technology Transfer (STTR) program
are itemized below. This list is meant to provide you with enough
information to help you decide to which program you should apply.
Consultation with program staff is always encouraged if questions
arise.
- The set-aside for the SBIR program is 2.5% of the extramural
budget; the set-aside for the STTR program is 0.15% of the extramural
budget.
- In Phase I SBIR grants, a minimum of 2/3 of the work MUST
be performed by the small business concern; in Phase I STTR
grants, a minimum of 40% of the work MUST be performed by the
small business concern AND a minimum of 30% MUST be performed
by the research institution.
- In Phase II SBIR grants, a minimum of 50% of the work MUST
be performed by the small business concern; in phase II STTR
grants, the same requirements as Phase I grants must be followed,
i.e. a minimum of 40% of the work MUST be performed by the small
business, a minimum of 30% by the research institution.
- For SBIR grants, the Principal Investigator must have his/her
primary employment with the small business concern; for STTR
grants, someone at either the small business concern or the
research institution may be the P.I.
- SBIR/STTR Application Instructions (PDF) | Forms
- Federal Financial and Business Management Systems Requirement - Sample Policies and Procedures
[Top]
SBIR/STTR Research Topics
Refer to the NIDDK Current Initiatives for SBIR and STTR initiative listings.
SBIR/STTR research topics are listed in the NIDDK section of the NIH Omnibus Solicitation (PDF).
[Top]
Additional Information
Applications
may be submitted for any of the yearly
receipt dates of April 1, August 1, and December 1.
For more information, contact your NIDDK
Program Director:
DIABETES, ENDOCRINOLOGY
AND METABOLIC DISEASES |
Islet Transplantation
Dr. Thomas Eggerman
(301) 594-8813 Fax: (301) 480-3510
Email: te39q@nih.gov |
Diabetes Therapy and Prevention
Dr. Sanford Garfield
(301) 594-8803 Fax: (301) 480-6271
Email: sg50o@nih.gov |
Gene Therapy, Metabolic Diseases,
and Cystic Fibrosis
Dr. Catherine McKeon
(301) 594-8810 Fax: (301) 480-3503
Email: cm67w@nih.gov |
Proteomics, Glucose Sensors,
Metabolic Profiling, and Hormone Action
Dr. Salvatore Sechi
(301) 594-8814 Fax: (301) 480-8814
Email: ss24q@nih.gov |
DIGESTIVE DISEASES AND
NUTRITION |
Digestive and Liver Diseases
(Clinical)
Dr. Frank Hamilton
(301) 594-8877 Fax: (301) 480-8300
Email: fh14e@nih.gov |
Digestive and Liver Diseases
(Basic)
Dr. Judith Podskalny
(301) 594-3197 Fax: (301) 480-8300
Email: jp53s@nih.gov |
Nutrition
Dr. M. Ken May
(301) 594-8884 Fax: (301) 480-8300
Email: mm102i@nih.gov |
Obesity and Eating Disorders
Carolyn Miles
(301) 451-3759 Fax: (301) 480-8300
Email: milesc@extra.niddk.nih.gov |
KIDNEY, UROLOGIC
AND HEMATOLOGIC DISEASES |
Kidney
Dr. Robert A. Star
(301) 594-7717 Fax: (301) 480-3510
Email: rs301p@nih.gov |
Urology
Dr. Leroy M. Nyberg
(301) 594-7717 Fax: (301) 480-3510
Email: ln10f@nih.gov |
Hematology
Dr. David G. Badman
(301) 594-7717 Fax: (301) 480-3510
Email: db70f@nih.gov |
|
For administrative and business management questions, contact:
Mrs. Helen Ling
Grants Management Specialist
National Institute of Diabetes and Digestive and Kidney Diseases
Democracy 2, Room 732
phone: (301) 594-8857;
Fax: (301) 480-3504;
email: lingh@extra.niddk.nih.gov
|
[Top]
|
|
|
|
|
Home ||
Welcome ||
Health Information ||
Research Funding Opportunities ||
Clinical Research ||
NIDDK Laboratories ||
Reports, Testimony & Plans ||
Site Map ||
FAQs ||
Contact NIDDK ||
Search
|
|
|
|
|
|
Director: Dr. Allen Spiegel || Contact NIDDK
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
is part of the National Institutes of Health, Bethesda, MD, USA. General inquiries may be addressed to Office of Communications and Public Liaison, NIDDK, NIH, Building 31, room 9A04 Center Drive, MSC 2560, Bethesda, MD 20892-2560, USA. || Privacy || Disclaimer || Copyright || Credits || Accessibility |
|
|
|
|
|
|